Showing 151-160 of 3305 results for "".
- Ludient Launches in US With AI-Driven Approach to Clinical Skincarehttps://modernaesthetics.com/news/ludient-launches-in-us-with-ai-driven-approach-to-clinical-skincare/2487480/Ludient, a clinical skincare brand developed by lululab, has officially launched in the United States, introducing an artificial intelligence (AI)-driven approach to skincare product development. According to the company, Ludient’s platform is powered by its proprietary luluTI™ technology,
- FDA Approves Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel for Midface Augmentationhttps://modernaesthetics.com/news/fda-approves-obagi-saypha-chiq-injectable-hyaluronic-acid-gel-for-midface-augmentation/2487470/Waldencast plc announced that the US Food and Drug Administration (FDA) has approved Obagi® saypha® ChIQ™ injectable hyaluronic acid (HA) gel, expanding the Obagi Medical injectable portfolio and strengthening the company’s position within the medical aesthetics market. According to the co
- Allergan Aesthetics Marks 8th Year of Partnership with Girls Inc. to Support Future Women in STEMhttps://modernaesthetics.com/news/allergan-aesthetics-marks-8th-year-of-partnership-with-girls-inc-to-support-future-women-in-stem/2487445/Allergan Aesthetics is continuing its commitment to supporting the next generation of women in science, technology, engineering, and mathematics (STEM) through its longstanding partnership with Girls Inc. On June 8, the company marked its eighth year collaborating with the nonprofit organi
- Allergan Aesthetics Report Explores What Aesthetic Consumers Want Nowhttps://modernaesthetics.com/news/allergan-aesthetics-report-explores-what-aesthetic-consumers-want-now/2487442/Allergan Aesthetics, an AbbVie company, released "What Consumers Really Want," the latest installment in its The Aesthetics Evolution series, examining how consumer motivations, expectations, and perceptions of aesthetic care are changing. The report follows
- New Anatomy-Based Framework Targets Prevention of GLP-1 RA-Associated Facial Aginghttps://modernaesthetics.com/news/new-anatomy-based-framework-targets-prevention-of-glp-1-ra-associated-facial-aging/2487408/A conceptual model published online ahead of print in Aesthetic Plastic Surgery proposes an anatomy-driven approach to identifying and preventing facial aging changes associated with glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, commonly referred to as “Ozempic face.”
- Review Examines Glycation’s Expanding Role in Cutaneous Aginghttps://modernaesthetics.com/news/review-examines-glycations-expanding-role-in-cutaneous-aging/2487357/A narrative review published in the Journal of Cosmetic Dermatology examines the growing evidence linking glycation and advanced glycation end products (AGEs) to skin aging, highlighting potential implications for both dermatology and aesthetic medicine. In the review, Diala Hayka
- Case Series Evaluates Anatomy-Based Thread Lifting for Nasolabial Fold Rejuvenationhttps://modernaesthetics.com/news/case-series-evaluates-anatomy-based-thread-lifting-for-nasolabial-fold-rejuvenation/2487262/A personalized, anatomy-guided thread lifting strategy using multiple vector patterns demonstrated favorable aesthetic outcomes for nasolabial fold (NLF) correction in a small retrospective case series published in JPRAS Open. In the study, investigators evaluated 22 patients trea
- Experts Discuss Microneedling and Acne Scar Management During Revance Virtual Desksidehttps://modernaesthetics.com/news/experts-discuss-microneedling-and-acne-scar-management-during-revance-virtual-deskside/2487258/Acne scarring remains a common concern even after active acne resolves, according to speakers during a virtual deskside hosted by Revance, with discussion centering on microneedling and the SkinPen device for facial acne scar treatment. Modern Aesthetics Editorial Board member Suneel Chilu
- FDA Clears Caliway’s Phase 3 CBL-514 Trial for Abdominal Fat Reductionhttps://modernaesthetics.com/news/fda-clears-caliways-phase-3-cbl-514-trial-for-abdominal-fat-reduction/2487183/Caliway Biopharmaceuticals announced that the US Food and Drug Administration (FDA) cleared the Investigational New Drug application for CBL-0302, also known as SUPREME-02, its second global pivotal phase 3 study of CBL-514 for abdominal subcutaneous fat reduction.1 The IND pass
- Imaging Study Explores Tissue Repair Dynamics After UltraClear Laser Therapyhttps://modernaesthetics.com/news/imaging-study-explores-tissue-repair-dynamics-after-ultraclear-laser-therapy/2487167/Serial line-field confocal optical coherence tomography (LC-OCT) imaging may provide a noninvasive method for visualizing tissue repair following laser-coring procedures, according to findings published in Lasers in Surgery and Medicine.1 In the technical demonstration